We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Take a company’s revenues over a given period of time, subtract the cost of production and you will have its earnings! Earnings growth enthralls almost everyone, right from the top brass to research analysts. And why not? If the company doesn’t make money, it won’t last over the long haul.
This metric is also considered a key variable in influencing the share price. Better-than-expected earnings performances normally lead to a rally in the share price. However, in addition to actual earnings, expectations of earnings play a significant role in influencing the price of a stock.
Earnings Estimates Determine Share Prices
We have often seen a decline in the stock price despite earnings growth and a rally in the price following an earnings decline. This is largely a result of a company’s earnings failing to meet market expectations.
Earnings estimates embody analysts’ opinions of factors such as sales growth, product demand, competitive industry environment, profit margins and cost control. Thus, earnings estimates serve as a valuable tool while making investment decisions. Earnings estimates also help analysts assess the cash flow to determine the fair value of a firm.
Investors, thus, should be on the lookout for stocks that are ready to make a big move. Hence, it is important for investors to buy stocks that have historical earnings growth and are also seeing a rise in quarterly and annual earnings estimates.
The Winning Strategy
In order to shortlist stocks that have striking earnings growth and positive estimate revisions, we have added the following parameters:
Zacks Rank less than or equal to 2 (Only Zacks' 'Buys' and 'Strong Buys' are allowed. With the Zacks Rank proving itself to be one of the best rating systems out there, this is a great way to start things off.)
5-Year Historical EPS Growth (%) greater than X-Industry (Stocks that possess strong EPS growth history.)
% Change EPS F(0)/F(-1) greater than or equal to 5 (Companies that witnessed year-over-year earnings growth rate of 5% or more in the last reported fiscal.)
% Change Q1 Estimates over the last 4 weeks greater than zero (Stocks that have seen their current quarter earnings estimates revised higher in the last 4 weeks.)
% Change F1 Estimates over the last 1 week greater than zero (Stocks that have seen their annual earnings estimates revised higher in the last 1 week.)
% Change F1 Estimates over the last 4 weeks greater than zero (Stocks that have seen their annual earnings estimates revised higher in the last 4 weeks.)
The above criteria narrowed down the universe of around 7,818 stocks to only nine.
Here are the top four stocks:
Darden Restaurants, Inc. (DRI - Free Report) owns and operates full-service restaurants in the United States and Canada. The stock currently has a Zacks Rank #2 (Buy). The company’s estimated earnings growth rate for this year is 18.3%, higher than the Retail - Restaurants industry’s estimated rise of 3.7%.
Best Buy Co., Inc. (BBY - Free Report) operates as a retailer of technology products, services, and solutions in the United States, Canada, and Mexico. The stock currently has a Zacks Rank #2. The company’s estimated earnings growth rate for this year is 5.6%, higher than the Retail - Consumer Electronics industry’s projected rise of 2.4%.
BioSpecifics Technologies Corp. is a biopharmaceutical company. The stock currently has a Zacks Rank #1 (Strong Buy). The company’s estimated earnings growth rate for this year is 55.3%, higher than the Medical - Drugs industry’s expected rise of 7.1%. You can see the complete list of today’s Zacks #1 Rank stocks here.
ONEOK, Inc. (OKE - Free Report) engages in the gathering, processing, storage, and transportation of natural gas in the United States. The stock currently has a Zacks Rank #2. The company’s estimated earnings growth rate for this year is 6.5%, higher than the Utility - Gas Distribution industry’s estimated rally of 4.1%.
You can get the rest of the stocks on this list by signing up now for your 2-week free trial to the Research Wizard and start using this screen in your own trading. Further, you can also create your own strategies and test them first before taking the investment plunge.
The Research Wizard is a great place to begin. It's easy to use. Everything is in plain language. And it's very intuitive. Start your Research Wizard trial today. And the next time you read an economic report, open up the Research Wizard, plug your finds in, and see what gems come out.
Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material.
Image: Bigstock
4 Top Stocks to Buy for Superb Earnings Growth
Take a company’s revenues over a given period of time, subtract the cost of production and you will have its earnings! Earnings growth enthralls almost everyone, right from the top brass to research analysts. And why not? If the company doesn’t make money, it won’t last over the long haul.
This metric is also considered a key variable in influencing the share price. Better-than-expected earnings performances normally lead to a rally in the share price. However, in addition to actual earnings, expectations of earnings play a significant role in influencing the price of a stock.
Earnings Estimates Determine Share Prices
We have often seen a decline in the stock price despite earnings growth and a rally in the price following an earnings decline. This is largely a result of a company’s earnings failing to meet market expectations.
Earnings estimates embody analysts’ opinions of factors such as sales growth, product demand, competitive industry environment, profit margins and cost control. Thus, earnings estimates serve as a valuable tool while making investment decisions. Earnings estimates also help analysts assess the cash flow to determine the fair value of a firm.
Investors, thus, should be on the lookout for stocks that are ready to make a big move. Hence, it is important for investors to buy stocks that have historical earnings growth and are also seeing a rise in quarterly and annual earnings estimates.
The Winning Strategy
In order to shortlist stocks that have striking earnings growth and positive estimate revisions, we have added the following parameters:
Zacks Rank less than or equal to 2 (Only Zacks' 'Buys' and 'Strong Buys' are allowed. With the Zacks Rank proving itself to be one of the best rating systems out there, this is a great way to start things off.)
5-Year Historical EPS Growth (%) greater than X-Industry (Stocks that possess strong EPS growth history.)
% Change EPS F(0)/F(-1) greater than or equal to 5 (Companies that witnessed year-over-year earnings growth rate of 5% or more in the last reported fiscal.)
% Change Q1 Estimates over the last 4 weeks greater than zero (Stocks that have seen their current quarter earnings estimates revised higher in the last 4 weeks.)
% Change F1 Estimates over the last 1 week greater than zero (Stocks that have seen their annual earnings estimates revised higher in the last 1 week.)
% Change F1 Estimates over the last 4 weeks greater than zero (Stocks that have seen their annual earnings estimates revised higher in the last 4 weeks.)
The above criteria narrowed down the universe of around 7,818 stocks to only nine.
Here are the top four stocks:
Darden Restaurants, Inc. (DRI - Free Report) owns and operates full-service restaurants in the United States and Canada. The stock currently has a Zacks Rank #2 (Buy). The company’s estimated earnings growth rate for this year is 18.3%, higher than the Retail - Restaurants industry’s estimated rise of 3.7%.
Best Buy Co., Inc. (BBY - Free Report) operates as a retailer of technology products, services, and solutions in the United States, Canada, and Mexico. The stock currently has a Zacks Rank #2. The company’s estimated earnings growth rate for this year is 5.6%, higher than the Retail - Consumer Electronics industry’s projected rise of 2.4%.
BioSpecifics Technologies Corp. is a biopharmaceutical company. The stock currently has a Zacks Rank #1 (Strong Buy). The company’s estimated earnings growth rate for this year is 55.3%, higher than the Medical - Drugs industry’s expected rise of 7.1%. You can see the complete list of today’s Zacks #1 Rank stocks here.
ONEOK, Inc. (OKE - Free Report) engages in the gathering, processing, storage, and transportation of natural gas in the United States. The stock currently has a Zacks Rank #2. The company’s estimated earnings growth rate for this year is 6.5%, higher than the Utility - Gas Distribution industry’s estimated rally of 4.1%.
You can get the rest of the stocks on this list by signing up now for your 2-week free trial to the Research Wizard and start using this screen in your own trading. Further, you can also create your own strategies and test them first before taking the investment plunge.
The Research Wizard is a great place to begin. It's easy to use. Everything is in plain language. And it's very intuitive. Start your Research Wizard trial today. And the next time you read an economic report, open up the Research Wizard, plug your finds in, and see what gems come out.
Click here to sign up for a free trial to the Research Wizard today.
Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material.
Disclosure: Performance information for Zacks’ portfolios and strategies are available at: https://www.zacks.com/performance